Provided by Tiger Trade Technology Pte. Ltd.

Benitec Biopharma

11.24
+0.19001.72%
Volume:47.36K
Turnover:532.33K
Market Cap:392.08M
PE:-10.15
High:11.45
Open:11.09
Low:11.01
Close:11.05
52wk High:16.76
52wk Low:9.85
Shares:34.88M
Float Shares:18.45M
Volume Ratio:0.70
T/O Rate:0.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1074
EPS(LYR):-0.9800
ROE:-33.21%
ROA:-22.67%
PB:2.21
PE(LYR):-11.47

Loading ...

BNTC: BB-301 Clinical Progress and Strong Cash Position Drive Ritu Baral’s Buy Rating

TIPRANKS
·
Yesterday

Benitec Biopharma price target raised to $17 from $16 at Wedbush

TIPRANKS
·
Sep 15

Analysts Offer Insights on Healthcare Companies: Benitec Biopharma (BNTC), CVS Health (CVS) and BioNTech SE (BNTX)

TIPRANKS
·
Sep 15

Wedbush Lifts Price Target on Benitec Biopharma to $17 From $16, Keeps Outperform Rating

MT Newswires Live
·
Sep 15

Benitec Biopharma Files $200 Million Shelf Registration

MT Newswires Live
·
Sep 15

Benitec Biopharma files $200M mixed securities shelf

TIPRANKS
·
Sep 15

Benitec Biopharma - May Offer Securities up to $200 Mln - SEC Filing

THOMSON REUTERS
·
Sep 15

Benitec Biopharma Q4 EPS $(0.26), Inline

Benzinga Earnings
·
Sep 15

Benitec Biopharma Publishes Fy2026 Annual Report

Reuters
·
Sep 15

Benitec Biopharma Releases Full Year 2026 Financial Results and Provides Operational Update

THOMSON REUTERS
·
Sep 15

Benitec Biopharma Initiated at Outperform by Wedbush

Dow Jones
·
Jul 28

Benitec Biopharma Inc : Wedbush Initiates Coverage with Outperform Rating; Target Price $16

THOMSON REUTERS
·
Jul 28

Wedbush Initiates Benitec Biopharma at Outperform With $16 Price Target

MT Newswires Live
·
Jul 28

Novartis Receives European Commission Approval for Itvisma® for Spinal Muscular Atrophy (SMA)

Reuters
·
Jul 07

Novartis Receives European Commission Approval for Itvisma® for Spinal Muscular Atrophy (SMA)

Reuters
·
Jul 02

Benitec Biopharma downgraded to Neutral from Buy at Guggenheim

TIPRANKS
·
Jun 10

Benitec Biopharma Announces Board Changes and New Director

TIPRANKS
·
May 30

BRIEF-Benitec Biopharma - CFO Megan Boston Resigns From Board Effective May 22, 2026

Reuters
·
May 30

Benitec Biopharma - Megan Boston to Continue as Chief Financial Officer and Secretary - SEC Filing

THOMSON REUTERS
·
May 30

Benitec Biopharma files Form 3 for director David Matthew Friedman

Reuters
·
May 29